Baker Brothers Advisors - ERYTECH PHARMA ownership

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of ERYTECH PHARMA
ValueSharesWeighting
Q3 2018$9,307,000
-73.0%
1,085,969
-64.8%
0.06%
-76.4%
Q2 2018$34,470,000
-46.9%
3,085,969
-0.1%
0.26%
-52.9%
Q1 2018$64,891,000
-4.6%
3,090,0690.0%0.55%
-6.8%
Q4 2017$68,043,0003,090,0690.59%
Other shareholders
ERYTECH PHARMA shareholders Q3 2023
NameSharesValueWeighting ↓
StoneX Group Inc. 17,304$130.00%
Baader Bank Aktiengesellschaft 24,000$14,7160.00%
Vanguard Personalized Indexing Management, LLC 24,271$18,6890.00%
Citadel Advisors 400$2920.00%
Citadel Advisors 16,606$12,1220.00%
Asset Dedication, LLC 4,000$30.00%
Ikarian Capital, LLC 3,019$2,2570.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 10,590$7,7310.00%
MILLENNIUM MANAGEMENT LLC 12,069$8,8100.00%
View complete list of ERYTECH PHARMA shareholders